Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis

Clinica Chimica Acta

Volumn 464, Issue , 2017, Pages 57-63

  Wang, Feng ^a   Han, Lili ^b   Hu, Dayi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b The People s Hospital of Zoucheng   (China)

Author keywords

Fasting insulin; HOMA IR; Hypertension; Insulin resistance; Meta analysis

Indexed keywords

INSULIN;

DATA EXTRACTION; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; POPULATION RISK; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; DIET RESTRICTION; META ANALYSIS; METABOLISM; PATHOPHYSIOLOGY; RISK;

FASTING; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; RISK;

EID: 84995495754     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.11.009     Document Type: Review

References (42)

1. [1] Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., He, J., Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005), 217–223.
2. [2] Bundy, J.D., He, J., Hypertension and related cardiovascular disease burden in China. Ann. Glob. Health 82 (2016), 227–233.
3. [3] Yang, G., Wang, Y., Zeng, Y., et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 381 (2013), 1987–2015.
4. [4] Schrezenmeir, J., Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome. Experientia 52 (1996), 426–432.
5. [5] Shanik, M.H., Xu, Y., Skrha, J., Dankner, R., Zick, Y., Roth, J., Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?. Diabetes Care 31:Suppl. 2 (2008), S262–S268.
6. [6] Lissner, L., Bengtsson, C., Lapidus, L., Kristjansson, K., Wedel, H., Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20 (1992), 797–801.
7. [7] Tsuruta, M., Hashimoto, R., Adachi, H., Imaizumi, T., Nomura, G., Hyperinsulinaemia as a predictor of hypertension: an 11-year follow-up study in Japan. J. Hypertens. 14 (1996), 483–488.
8. [8] Salonen, J.T., Lakka, T.A., Lakka, H.M., Valkonen, V.P., Everson, S.A., Kaplan, G.A., Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47 (1998), 270–275.
9. [9] He, J., Klag, M.J., Caballero, B., Appel, L.J., Charleston, J., Whelton, P.K., Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch. Intern. Med. 159 (1999), 498–503.
10. [10] Arima, H., Kiyohara, Y., Kato, I., et al. Alcohol reduces insulin-hypertension relationship in a general population: the Hisayama study. J. Clin. Epidemiol. 55 (2002), 863–869.
11. [11] Levin, G., Kestenbaum, B., Ida Chen, Y.D., et al. Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 172 (2010), 1144–1154.
12. [12] Sung, K.C., Lim, S., Rosenson, R.S., Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am. J. Hypertens. 24 (2011), 1041–1045.
13. [13] Xun, P., Liu, K., Cao, W., Sidney, S., Williams, O.D., He, K., Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study. Diabetes Care 35 (2012), 1532–1537.
14. [14] Fagot-Campagna, A., Balkau, B., Simon, D., Ducimetiere, P., Eschwege, E., Is insulin an independent risk factor for hypertension? The Paris prospective study. Int. J. Epidemiol. 26 (1997), 542–550.
15. [15] Xun, P., Wu, Y., He, Q., He, K., Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 98 (2013), 1543–1554.
16. [16] Lytsy, P., Ingelsson, E., Lind, L., Arnlov, J., Sundstrom, J., Interplay of overweight and insulin resistance on hypertension development. J. Hypertens. 32 (2014), 834–839.
17. [17] Park, S.K., Jung, J.Y., Choi, W.J., et al. Elevated fasting serum insulin level predicts future development of hypertension. Int. J. Cardiol. 172 (2014), 450–455.
18. [18] Arshi, B., Tohidi, M., Derakhshan, A., Asgari, S., Azizi, F., Hadaegh, F., Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population. J. Hum. Hypertens. 29 (2015), 260–267.
19. [19] Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
20. [20] Wells, G., Shea, B., O'Connell, D., et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed March 6, 2016).
21. [21] Higgins, J.P.T., Green, S., Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 (Available from www.cochrane-handbook.org.(accessed March 9, 2016)).
22. [22] Fujita, M., Hata, A., Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: a large historical cohort study. J. Am. Soc. Hypertens. 8 (2014), 64–70.
23. [23] Kidambi, S., Kotchen, J.M., Krishnaswami, S., Grim, C.E., Kotchen, T.A., Hypertension, insulin resistance, and aldosterone: sex-specific relationships. J. Clin. Hypertens. (Greenwich) 11 (2009), 130–137.
24. [24] Enzi, G., Gasparo, M., Biondetti, P.R., Fiore, D., Semisa, M., Zurlo, F., Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44 (1986), 739–746.
25. [25] Amati, F., Pennant, M., Azuma, K., et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity 20 (2012), 1115–1117.
26. [26] Hall, J.E., Summers, R.L., Brands, M.W., Keen, H., Alonso-Galicia, M., Resistance to metabolic actions of insulin and its role in hypertension. Am. J. Hypertens. 7 (1994), 772–788.
27. [27] Cheung, B.M., Wat, N.M., Man, Y.B., et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am. J. Hypertens. 21 (2008), 17–22.
28. [28] Halperin, R.O., Sesso, H.D., Ma, J., Buring, J.E., Stampfer, M.J., Gaziano, J.M., Dyslipidemia and the risk of incident hypertension in men. Hypertension 47 (2006), 45–50.
29. [29] Laaksonen, D.E., Niskanen, L., Nyyssonen, K., Lakka, T.A., Laukkanen, J.A., Salonen, J.T., Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur. Heart J. 29 (2008), 2561–2568.
30. [30] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
31. [31] Borai, A., Livingstone, C., Kaddam, I., Ferns, G., Selection of the appropriate method for the assessment of insulin resistance. BMC Med. Res. Methodol., 11, 2011, 158.
32. [32] DeFronzo, R.A., The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 21 (1981), 165–171.
33. [33] Nickenig, G., Roling, J., Strehlow, K., Schnabel, P., Bohm, M., Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 98 (1998), 2453–2460.
34. [34] Fonseca, V.A., Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease. J. Clin. Hypertens. (Greenwich) 8 (2006), 713–720 (quiz 721–712).
35. [35] Anderson, E.A., Hoffman, R.P., Balon, T.W., Sinkey, C.A., Mark, A.L., Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87 (1991), 2246–2252.
36. [36] Janus, A., Szahidewicz-Krupska, E., Mazur, G., Doroszko, A., Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediat. Inflamm., 2016, 2016, 3634948.
37. [37] Busija, D.W., Miller, A.W., Katakam, P., Erdos, B., Insulin resistance and associated dysfunction of resistance vessels and arterial hypertension. Minerva Med. 96 (2005), 223–232.
38. [38] Karaca, U., Schram, M.T., Houben, A.J., Muris, D.M., Stehouwer, C.D., Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res. Clin. Pract. 103 (2014), 382–387.
39. [39] Zhang, T., Zhang, H., Li, S., et al. Impact of adiposity on incident hypertension is modified by insulin resistance in adults: longitudinal observation from the Bogalusa heart study. Hypertension 67 (2016), 56–62.
40. [40] Smith, M.M., Minson, C.T., Obesity and adipokines: effects on sympathetic overactivity. J. Physiol. 590 (2012), 1787–1801.
41. [41] Hall, J.E., do Carmo, J.M., da Silva, A.A., Wang, Z., Hall, M.E., Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ. Res. 116 (2015), 991–1006.
42. [42] Wallace, T.M., Levy, J.C., Matthews, D.R., Use and abuse of HOMA modeling. Diabetes Care 27 (2004), 1487–1495.